Lucas Montarce

Executive Vice President and Chief Financial Officer (principal financial officer), ELI LILLY & Co

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Lucas Montarce signed the annual report of ELI LILLY & Co as Executive Vice President and Chief Financial Officer (principal financial officer); the report was filed on February 12, 2026, the most recent filing in the record that ties Lucas Montarce to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
ELI LILLY & Co (LLY) Pharmaceutical Preparations	Executive Vice President and Chief Financial Officer (principal financial officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 12, 202610-K filed
Lucas Montarce signed the annual report of ELI LILLY & Co on Form 10-K as Executive Vice President and Chief Financial Officer (principal financial officer), filed February 12, 2026.
/s/ Lucas Montarce Executive Vice President and Chief Financial Officer (principal financial officer)
[1] Annual report on Form 10-K by ELI LILLY & Co, filed with the SEC on February 12, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, ELI LILLY & Co. U.S. Securities and Exchange Commission, EDGAR, filed February 12, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Lucas Montarce wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.